Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Planned sale Director sold 46,534 shares at $30.05 ($1,398,347)
  2. 4 Planned sale 10% owner sold 46,534 shares at $30.05 ($1,398,347)
  3. 4 Planned sale CEO & President sold 100,000 shares at an average $28.96 ($2,895,519)
  4. 4 Planned sale Chief Business Officer sold 28,528 shares at an average $28.46 ($811,865)
  5. 4 Planned sale SVP, Head of Finance & Admin. sold 12,740 shares at an average $28.05 ($357,296)
  6. 4 Planned sale Director sold 807,838 shares at an average $24.30 ($19,626,903)
  7. 4 Planned sale 10% owner sold 807,838 shares at an average $24.30 ($19,626,903)
  8. 4 Planned sale Chief Medical Officer sold 407 shares at $25.00 ($10,175)
  9. 4 Planned sale Director sold 500,789 shares at an average $22.64 ($11,339,780)
  10. 4 Planned sale 10% owner sold 500,789 shares at an average $22.64 ($11,339,780)
  11. 4 Planned sale Director sold 510,152 shares at an average $23.26 ($11,867,292)
  12. 4 Planned sale 10% owner sold 510,152 shares at an average $23.26 ($11,867,292)
  13. 4 Planned sale Chief Medical Officer sold 5,493 shares at $25.07 ($137,710)
  14. 4 Gift CEO & President gave 21,500 shares (gift)
  15. 4 Planned sale Chief Medical Officer sold 100 shares at $25.00 ($2,500)
  16. 4 Planned sale Chief Business Officer sold 20,000 shares at an average $24.53 ($490,510)
  17. 4 Planned sale SVP, Head of Finance & Admin. sold 13,000 shares at $24.34 ($316,420)
  18. 4 Open-market buy Director bought 1,714,285 shares at $17.50 ($29,999,988)
  19. 4 Planned sale CEO & President sold 269,719 shares at an average $18.66 ($5,032,915)
  20. 4 Planned sale Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)

Page 10 of 19 · 361 filings